Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chiagozie Pickens"'
Publikováno v:
Diagnostics, Vol 14, Iss 13, p 1388 (2024)
Introduction: In patients with suspected pneumonia who are tested with respiratory culture and multiplex PCR, the potential added benefit of next-generation sequencing technologies is unknown. Methods: This was a single-center, retrospective study in
Externí odkaz:
https://doaj.org/article/1d6bf97e71e3495692f6b3fd8d046096
Autor:
Catherine A. Gao, Nikolay S. Markov, Thomas Stoeger, Anna Pawlowski, Mengjia Kang, Prasanth Nannapaneni, Rogan A. Grant, Chiagozie Pickens, James M. Walter, Jacqueline M. Kruser, Luke Rasmussen, Daniel Schneider, Justin Starren, Helen K. Donnelly, Alvaro Donayre, Yuan Luo, G.R. Scott Budinger, Richard G. Wunderink, Alexander V. Misharin, Benjamin D. Singer, The NU SCRIPT Study Investigators
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 12 (2023)
BACKGROUND Despite guidelines promoting the prevention and aggressive treatment of ventilator-associated pneumonia (VAP), the importance of VAP as a driver of outcomes in mechanically ventilated patients, including patients with severe COVID-19, rema
Externí odkaz:
https://doaj.org/article/f2a85cfc68d846f1a4d5f04bb23bd1d4
Autor:
Catherine A. Gao, Benjamin Singer, Helen K Donnelly, James Walter, Alvaro Donayre, Jacqueline Kruser, Rebecca K. Clepp, Chiagozie Pickens
RationaleClinical endpoints that constitute successful treatment in severe pneumonia are difficult to ascertain and vulnerable to bias. Utility of a protocolized adjudication procedure to determine meaningful endpoints in severe pneumonia is not well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f3d687833ff9f64db1b8fc5b62a3cb5
https://doi.org/10.1101/2022.10.26.22281461
https://doi.org/10.1101/2022.10.26.22281461
Autor:
Catherine A. Gao, Benjamin Singer, Anna Pawlowski, James Walter, Jacqueline Kruser, Chiagozie Pickens, Nikolay Markov, Mengjia Kang, Thomas Stoeger
BackgroundPatients with severe SARS-CoV-2 pneumonia experience longer durations of critical illness yet similar mortality rates compared to patients with severe pneumonia secondary to other etiologies. As secondary bacterial infection is common in SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adadd9769553ac28be8e7c9c2bfa5342
https://doi.org/10.1101/2022.09.23.22280118
https://doi.org/10.1101/2022.09.23.22280118
Publikováno v:
Frontiers in Cellular and Infection Microbiology. 12
Pneumonia is one of the leading causes of morbidity and mortality worldwide and Gram-negative bacteria are a major cause of severe pneumonia. Despite advances in diagnosis and treatment, the rise of multidrug-resistant organisms and hypervirulent str